<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Teschendorff AE</submitter><funding>Public Health Agency</funding><funding>NCI NIH HHS</funding><funding>Wellcome Trust</funding><pagination>440-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2847747</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(4)</volume><pubmed_abstract>Polycomb group proteins (PCGs) are involved in repression of genes that are required for stem cell differentiation. Recently, it was shown that promoters of PCG target genes (PCGTs) are 12-fold more likely to be methylated in cancer than non-PCGTs. Age is the most important demographic risk factor for cancer, and we hypothesized that its carcinogenic potential may be referred by irreversibly stabilizing stem cell features. To test this, we analyzed the methylation status of over 27,000 CpGs mapping to promoters of approximately 14,000 genes in whole blood samples from 261 postmenopausal women. We demonstrate that stem cell PCGTs are far more likely to become methylated with age than non-targets (odds ratio = 5.3 [3.8-7.4], P &lt; 10(-10)), independently of sex, tissue type, disease state, and</pubmed_abstract><journal>Genome research</journal><pubmed_title>Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.</pubmed_title><pmcid>PMC2847747</pmcid><funding_grant_id>R01-CA096958</funding_grant_id><funding_grant_id>STL/3714/07</funding_grant_id><funding_grant_id>R01 CA096958</funding_grant_id><funding_grant_id>R01 CA075090</funding_grant_id><pubmed_authors>Kocjan G</pubmed_authors><pubmed_authors>Beck S</pubmed_authors><pubmed_authors>Savage DA</pubmed_authors><pubmed_authors>Gayther SA</pubmed_authors><pubmed_authors>Maxwell AP</pubmed_authors><pubmed_authors>Jacobs IJ</pubmed_authors><pubmed_authors>Jones A</pubmed_authors><pubmed_authors>Shen H</pubmed_authors><pubmed_authors>Noushmehr H</pubmed_authors><pubmed_authors>Menon U</pubmed_authors><pubmed_authors>Widschwendter M</pubmed_authors><pubmed_authors>Wagner W</pubmed_authors><pubmed_authors>Laird PW</pubmed_authors><pubmed_authors>Marth C</pubmed_authors><pubmed_authors>Campan M</pubmed_authors><pubmed_authors>Ramus SJ</pubmed_authors><pubmed_authors>Bell CG</pubmed_authors><pubmed_authors>Mueller-Holzner E</pubmed_authors><pubmed_authors>Gentry-Maharaj A</pubmed_authors><pubmed_authors>Teschendorff AE</pubmed_authors><pubmed_authors>Weisenberger DJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.</name><description>Polycomb group proteins (PCGs) are involved in repression of genes that are required for stem cell differentiation. Recently, it was shown that promoters of PCG target genes (PCGTs) are 12-fold more likely to be methylated in cancer than non-PCGTs. Age is the most important demographic risk factor for cancer, and we hypothesized that its carcinogenic potential may be referred by irreversibly stabilizing stem cell features. To test this, we analyzed the methylation status of over 27,000 CpGs mapping to promoters of approximately 14,000 genes in whole blood samples from 261 postmenopausal women. We demonstrate that stem cell PCGTs are far more likely to become methylated with age than non-targets (odds ratio = 5.3 [3.8-7.4], P &lt; 10(-10)), independently of sex, tissue type, disease state, and</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Apr</publication><modification>2025-04-03T22:16:19.201Z</modification><creation>2019-06-06T21:58:25Z</creation></dates><accession>S-EPMC2847747</accession><cross_references><pubmed>20219944</pubmed><doi>10.1101/gr.103606.109</doi></cross_references></HashMap>